An unexpected, pH-sensitive step of the enterovirus D68 lifecycle.
mBio.
2023 Nov 1;14(6):e0228123. doi: 10.1128/mbio.02281-23. [Epub ahead of print] PubMed PMID:
37909766; PubMed Central PMCID:
PMC10746263.
Nonpolio Enteroviruses.
In:
Orenstein WA, Offit PA, Edwards KM, Plotkin SA, editors.
Plotkin's Vaccines
8 ed. Philadelphia: Elsevier; 2023. Chapter 23; p.330-340. 1808p.
A counterintuitive antibody cocktail disrupts coxsackievirus.
Cell Host Microbe.
2022 Sep 14;30(9):1194-1195. doi: 10.1016/j.chom.2022.08.010. PubMed PMID:
36108609; PubMed Central PMCID:
PMC9472682.
Enterovirus D68 in the Anterior Horn Cells of a Child with Acute Flaccid Myelitis.
N Engl J Med.
2022 May 26;386(21):2059-2060. doi: 10.1056/NEJMc2118155. PubMed PMID:
35613028; PubMed Central PMCID:
PMC9321432.
Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens.
Lancet Microbe.
2022 Feb;3(2):e83-e85. doi: 10.1016/S2666-5247(21)00312-8. Epub 2022 Jan 7. PubMed PMID:
35036969; PubMed Central PMCID:
PMC8741221.
A Severe Case of Enterovirus A71 Acute Flaccid Myelitis With Encephalitis.
J Pediatric Infect Dis Soc.
2020 Dec 31;9(6):777-780. doi: 10.1093/jpids/piaa067. PubMed PMID:
32535628.
Enterovirus D68 Visualized in the Anterior Horn of the Spinal Cord of a Pediatric Patient with Flaccid Paralysis.
IDWeek 2020 Abstracts. IDWeek 2020; 2020 October; Philadelphia, PA, USA. Volume 7, Issue Supplement_1, Page S712: Open Forum Infectious Diseases; c2020.
Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease.
Sci Immunol.
2020 Jul 3;5(49). doi: 10.1126/sciimmunol.aba4902. PubMed PMID:
32620559; PubMed Central PMCID:
PMC7418079.
Human Monoclonal Antibodies Potently Neutralize Enterovirus D68 in both a Clade-Specific and -Independent Manner.
IDWeek 2019 Abstracts. IDWeek 2019; 2019 October; Washington, D.C., United States. Volume 6, Issue Supplement_2, Page S901: Open Forum Infectious Diseases; c2019.
Current Understanding of Humoral Immunity to Enterovirus D68.
J Pediatric Infect Dis Soc.
2018 Dec 26;7(suppl_2):S49-S53. doi: 10.1093/jpids/piy124. Review. PubMed PMID:
30590621.
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.
J Virol.
2011 Nov;85(22):11567-80. doi: 10.1128/JVI.05859-11. Epub 2011 Sep 14. PubMed PMID:
21917960; PubMed Central PMCID:
PMC3209272.
Beta interferon controls West Nile virus infection and pathogenesis in mice.
J Virol.
2011 Jul;85(14):7186-94. doi: 10.1128/JVI.00396-11. Epub 2011 May 4. PubMed PMID:
21543483; PubMed Central PMCID:
PMC3126609.
Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354.
Proc Natl Acad Sci U S A.
2010 Nov 2;107(44):18950-5. doi: 10.1073/pnas.1011036107. Epub 2010 Oct 18. PubMed PMID:
20956322; PubMed Central PMCID:
PMC2973864.
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.
Virol J.
2010 May 12;7:95. doi: 10.1186/1743-422X-7-95. PubMed PMID:
20462412; PubMed Central PMCID:
PMC2885341.
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.
J Infect Dis.
2009 Jul 15;200(2):202-5. doi: 10.1086/599794. PubMed PMID:
19527169; PubMed Central PMCID:
PMC2752978.
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
J Virol.
2009 Jul;83(13):6494-507. doi: 10.1128/JVI.00286-09. Epub 2009 Apr 22. PubMed PMID:
19386704; PubMed Central PMCID:
PMC2698525.
What would you like to do?